Stoke Therapeutics (STOK) Balance Sheet: Assets & Liabilities

Stoke Therapeutics (STOK) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Stoke Therapeutics reported total assets of $418.43M and total liabilities of $65.98M. Shareholders' equity was $352.46M, up 53.9% from $229.02M a year earlier. Total debt stood at $3.01M against $284.67M in cash and short-term investments, a net cash position of $281.66M. That puts debt-to-equity at 0.01, compared with 0.02 a year earlier.

Stoke Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Stoke Therapeutics, Inc. (STOK) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	84.22	127.98	191.44	113.56	144.90	287.31	222.47	105.40	1.80
Short-Term Investments	200.45	88.92	9.95	116.04	74.92	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	284.67	216.90	201.39	229.60	219.81	287.31	222.47	105.40	1.80
Accounts Receivable	5.94	0.70	0.06	0.59	0.13	0.01	0.28	0.20	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	12.63	15.16	13.88	2.96	9.28	6.44	3.28	0.55	0.11
Total Current Assets	305.70	232.76	215.34	244.07	229.22	293.93	226.03	106.14	1.91
Non-Current Assets
Property, Plant & Equipment (Net)	6.25	8.25	12.43	11.43	9.08	3.79	2.51	1.19	0.47
Long-Term Investments	106.26	29.82	0.00	0.00	0.00	0.00	0.00	0.20	0.06
Other Non-Current Assets	0.23	0.72	0.57	0.57	0.57	0.21	0.21	0.00	0.00
Total Non-Current Assets	112.73	38.80	13.00	12.00	9.65	4.00	2.72	1.40	0.53
Total Assets	418.43	271.56	228.34	256.07	238.87	297.93	228.75	107.54	2.44
Current Liabilities
Accounts Payable	4.94	2.50	1.70	0.77	2.39	1.50	0.75	1.07	0.14
Short-Term Debt	3.01	2.32	2.06	2.36	1.51	1.07	0.00	0.00	3.00
Accrued Liabilities	41.04	7.81	13.82	7.13	14.75	8.41	-	-	-
Deferred Revenue	11.90	18.99	15.31	14.88	0.00	0.00	0.00	0.00	-3.00
Other Current Liabilities	38.03	16.25	0.86	0.51	0.54	0.46	3.35	1.40	0.57
Total Current Liabilities	57.88	40.06	30.82	31.39	17.14	11.43	4.10	2.47	3.72
Non-Current Liabilities
Long-Term Debt	0.00	2.45	0.00	0.00	3.53	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	8.10	0.03	37.96	2.97	3.95	0.34	0.22	0.00	0.02
Total Non-Current Liabilities	8.10	2.48	37.96	39.82	3.95	0.42	0.22	0.00	0.02
Total Liabilities	65.98	42.53	68.78	71.22	21.09	11.85	4.32	2.47	3.73
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-497.72	-490.83	-401.85	-297.15	-196.08	-110.28	-58.04	-25.71	-13.19
Accumulated Other Comprehensive Income	0.54	-0.15	-0.02	-1.18	-0.17	0.00	0.00	-0.38	-0.17
Additional Paid-in Capital	849.62	720.00	561.43	483.17	414.02	396.35	282.46	130.78	11.89
Shares Outstanding	58.92	54.03	45.92	39.44	36.90	-	-	-	-
Total Stockholders' Equity	352.46	229.02	159.57	184.85	217.78	286.08	224.43	105.07	-1.29
Total Liabilities & Equity	418.43	271.56	228.34	256.07	238.87	297.93	228.75	107.54	2.44

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Stoke Therapeutics Balance Sheet

How much debt does Stoke Therapeutics have?

Stoke Therapeutics had total debt of $3.01M as of Dec 31, 2025, against $284.67M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $4.77M a year earlier.

What are Stoke Therapeutics's total assets?

Stoke Therapeutics reported total assets of $418.43M as of Dec 31, 2025, up 54.1% from $271.56M a year earlier. Total liabilities were $65.98M.

What is Stoke Therapeutics's shareholders' equity?

Stoke Therapeutics's shareholders' equity was $352.46M as of Dec 31, 2025, or about $5.98 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition